Trial-Only Medicare Coverage Proposed For PET Alzheimer’s Scans
This article was originally published in The Gray Sheet
Executive Summary
Beta amyloid positron emission tomography scans to help diagnose dementia would only be covered by Medicare as part of a clinical trial under a proposed national coverage decision. Eli Lilly requested broader coverage for its Amyvid PET imaging agent.